 |
 |

Bone Densitometry Testing in Nonwhite Patients
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
To the Editor: In their Scientific Review article on the clinical use of bone densitometry, Dr Cummings and colleagues1 state that bone mineral density (BMD) should be measured in white women older than 65 years and, perhaps, in younger postmenopausal women with appropriate risk factors. Osteoporosis and low bone mass are estimated to exist in about 44 million US women and men aged 50 years or older. Of these, 10.1 million have established osteoporosis, a number predicted to increase to 12 million by 2010.2
Because the prevalence of osteoporosis increases with age, it follows that such an increase will also occur in nonwhite populations as they age. Although data for Hispanic, Asian, and African American populations are substantially less complete, and although African Americans tend to have higher BMD than whites, it is clear that osteoporosis and osteoporosis-related fractures constitute a significant problem in these groups.3-4 Indeed, these individuals experience . . . [Full Text of this Article]
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLE
Clinical Use of Bone Densitometry: Scientific Review
Steven R. Cummings, David Bates, and Dennis M. Black
JAMA. 2002;288(15):1889-1897.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Understanding Osteoporosis Prevalence in Hispanic Women
EVANS and TAYLOR
radtech 2006;77:451-459.
ABSTRACT
| FULL TEXT
Vitamins E and C are safe across a broad range of intakes
Hathcock et al.
Am. J. Clin. Nutr. 2005;81:736-745.
ABSTRACT
| FULL TEXT
|